Myomo Inc. (MYO) Dividend History

Myomo Inc. is a medical robotics company specializing in wearable, powered orthoses designed to assist individuals with arm and hand paralysis due to neurological conditions. The company's flagship product, MyoPro, uses robotic technology to restore some degree of movement and independence to users, primarily serving patients with conditions such as stroke, brachial plexus injury, and spinal cord injury. Founded in 2009 and based in Cambridge, Massachusetts, Myomo focuses on developing innovative neurorehabilitation solutions that enhance quality of life.

Dividend History

Myomo Inc. currently does not pay dividends

Company News

  • Myomo, Inc. (MYO) delivered earnings and revenue surprises of -40% and 1.19%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
  • Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income per share between $2.73 and $2.77. Zscaler shares fell 10.1% to $217.43 on Friday. Here are some other stocks moving in today's mid-day session. Gainers BioVie Inc. (NASDAQ: BIVI) shares climbed 96.1% to $2.4319. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 68.4% to $3.4350. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Cardiff Oncology, Inc. (NASDAQ: CRDF) shares rose 41.5% to $2.50 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial. Minim, Inc. (NASDAQ: MINM) shares rose 41.4% to $6.09. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock. The RealReal, Inc. (NASDAQ: REAL) gained 39.1% to $2.4613 following upbeat quarterly results. Nxu, Inc. (NASDAQ: NXU) shares gained 36.4% to $1.09 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26. Jaguar Health, Inc. (NASDAQ: JAGX) climbed 35.3% to $0.0798. Dell Technologies Inc. (NYSE: DELL) rose 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%. Sweetgreen, Inc. (NYSE: SG) gained 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results. MMTec, Inc. (NASDAQ: MTC) climbed 25% to $1.61. Everbridge, Inc. (NASDAQ: EVBG) rose 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo. NetApp, Inc. (NASDAQ: NTAP) shares gained 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results ...

    Benzinga
  • Penny stocks under $1 to watch right now. The post 10 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: ADIL
Page data last updated 07/23/2025 08:18:23 UTC